Viewing Study NCT00093704


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2026-03-28 @ 4:44 PM
Study NCT ID: NCT00093704
Status: TERMINATED
Last Update Posted: 2020-07-31
First Post: 2004-10-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module